Skip to main content
. 2017 Jul 27;37(4):BSR20170020. doi: 10.1042/BSR20170020

Table 3. Grades 3 and 4 AEs of patients with advanced NSCLC.

AEs Placebo (n=46) Nab-paclitaxel (n=46)
Number % Number %
Total 4 6.5 16 34.8
Rash 0 0 4 8.7
Nausea 1 2.2 3 6.5
Vomiting 0 0 2 4.3
Stomatitis 0 0 2 4.3
Pruritus 0 0 0 0
Anorexia 0 0 3 6.5
Diarrhoea 2 4.3 6 13.0
Paronychia 0 0 3 6.5
Fatigue 1 2.2 6 13.0
Infection 0 0 5 10.9
Thrombocytopaenia 1 2.2 4 8.7
Pulmonary fibrosis 0 0 2 4.3
Leucopenia 2 4.3 5 10.9